Structures by: Quiroga J.
Total: 176
7-Amino-2,5-dimethylpyrazolo[1,5-a]pyrimidine hemihydrate
C8H10N4,0.5H2O
Acta Crystallographica Section C (2006) 62, 4 o186-o189
a=16.0851(5)Å b=7.9458(3)Å c=8.0003(3)Å
α=90.00° β=117.309(2)° γ=90.00°
2-(4-Chlorophenyl)-5,8,8-trimethyl-6,7,8,9- tetrahydropyrazolo[2,3-a]quinazolin-6-one
C19H18ClN3O
Acta Crystallographica Section C (2006) 62, 6 o364-o368
a=8.5280(12)Å b=8.8610(14)Å c=11.7340(16)Å
α=100.992(10)° β=93.118(15)° γ=110.524(9)°
2-(4-Methoxyphenyl)-5,8,8-trimethyl-6,7,8,9- tetrahydropyrazolo[2,3-a]quinazolin-6-one
C20H21N3O2
Acta Crystallographica Section C (2006) 62, 6 o364-o368
a=17.7659(6)Å b=8.5730(2)Å c=11.3982(3)Å
α=90.00° β=101.094(2)° γ=90.00°
2-(4-Chlorophenyl)-8,8-dimethyl-5-phenyl-6,7,8,9- tetrahydropyrazolo[2,3-a]quinazolin-6-one
C24H20ClN3O
Acta Crystallographica Section C (2006) 62, 6 o364-o368
a=7.6778(2)Å b=8.1298(3)Å c=16.6417(5)Å
α=89.080(2)° β=85.123(2)° γ=72.490(2)°
2-(4-Methylphenyl)-8,8-dimethyl-6,7,8,9- tetrahydropyrazolo[2,3-a]quinazolin-6-one monohydrate
C19H19N3O,H2O
Acta Crystallographica Section C (2006) 62, 6 o364-o368
a=5.8190(7)Å b=10.4640(13)Å c=13.847(2)Å
α=78.447(12)° β=79.647(9)° γ=84.882(12)°
3-(3-Oxo-1,3-dihydroisobenzofuran-1-ylidene)pentane-2,4-dione
C13H10O4
Acta Crystallographica Section C (2007) 63, 6 o332-o333
a=8.2779(3)Å b=8.4719(6)Å c=15.1413(12)Å
α=90.0° β=95.534(6)° γ=90.0°
8-<i>tert</i>-Butyl-7-(4-chlorophenyl)-10-phenyl-5,6-dihydro-10<i>H</i>- benzo[<i>h</i>]pyrazolo[3,4-<i>b</i>]quinoline
C30H26ClN3
Acta Crystallographica Section C (2007) 63, 10 o582-o584
a=13.1170(18)Å b=15.948(3)Å c=17.717(2)Å
α=93.750(11)° β=91.803(9)° γ=101.155(13)°
(<i>E</i>)-<i>N</i>-{[6-Chloro-4-(4-chlorophenyl)-3-methyl-1-phenyl-1<i>H</i>- pyrazolo[3,4-<i>b</i>]pyridin-5-yl]methylene}benzene-1,2-diamine
C26H19Cl2N5
Acta Crystallographica Section C (2010) 66, 3 o137-o140
a=10.013(2)Å b=12.3487(12)Å c=17.666(4)Å
α=90.00° β=90.00° γ=90.00°
6-(4-bromophenyl)-3-methyl-1-phenyl-4,5-dihydro-1<i>H</i>- pyrazolo[3,4-<i>b</i>]pyridine
C19H16BrN3
Acta Crystallographica Section C (2010) 66, 4 o163-o167
a=7.51650(10)Å b=11.6572(3)Å c=17.6917(5)Å
α=90.00° β=92.701(2)° γ=90.00°
3-(4-nitrophenyl)-4-phenyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine
C18H12N4O2
Acta Crystallographica Section C (2010) 66, 4 o163-o167
a=7.04080(10)Å b=9.6360(3)Å c=11.1961(3)Å
α=84.9060(10)° β=89.177(2)° γ=81.012(2)°
9-(4-Chlorophenyl)-7-methyl-5,6-dihydrobenzo[h]pyrazolo[3,2-b]quinazoline
C21H16ClN3
Acta Crystallographica Section C (2004) 60, 8 o604-o607
a=9.2382(8)Å b=10.3054(8)Å c=10.3184(9)Å
α=62.720(4)° β=83.098(4)° γ=70.531(5)°
2-(4-Chlorophenyl)-5-methyl-6,7-dihydrobenzo[e]pyrazolo[2,3-b]quinazoline
C21H16ClN3
Acta Crystallographica Section C (2004) 60, 8 o604-o607
a=7.0098(3)Å b=15.0306(7)Å c=17.0060(8)Å
α=111.492(2)° β=101.406(3)° γ=97.981(3)°
7-Benzyl-3-<i>tert</i>-butyl-1-phenyl-4,5,6,7-tetrahydro-1<i>H</i>-spiro[pyrazolo[3,4-<i>b</i>]pyridine-5,2'-indan]-1',3'-dione
C31H29N3O2
Acta Crystallographica Section C (2013) 69, 8 884-887
a=16.6917(18)Å b=5.9748(4)Å c=24.840(3)Å
α=90.00° β=91.841(10)° γ=90.00°
Methyl (1<i>RS</i>,3<i>SR</i>,3a<i>RS</i>,6a<i>SR</i>)-1-methyl-3-(3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)-4,6-dioxo-5-phenyloctahydropyrrolo[3,4-<i>c</i>]pyrrole-1-carboxylate
C25H24N4O4
Acta Crystallographica Section C (2013) 69, 8 915-919
a=11.355(2)Å b=20.025(4)Å c=10.4124(8)Å
α=90.00° β=110.030(9)° γ=90.00°
Methyl (1<i>RS</i>,3<i>SR</i>,3a<i>RS</i>,6a<i>SR</i>)-5-(4-chlorophenyl)-1-methyl-3-(3-methyl-1-phenyl-1<i>H</i>-pyrazol-4-yl)-4,6-dioxooctahydropyrrolo[3,4-<i>c</i>]pyrrole-1-carboxylate
C25H23ClN4O4
Acta Crystallographica Section C (2013) 69, 8 915-919
a=16.565(3)Å b=6.9529(5)Å c=21.010(4)Å
α=90.00° β=110.465(11)° γ=90.00°
3-<i>tert</i>-butyl-7-(2,3-dimethoxybenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione
C32H39N3O4
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=12.4683(15)Å b=10.2892(12)Å c=21.7635(16)Å
α=90.00° β=90.843(10)° γ=90.00°
3-<i>tert</i>-butyl-4',4'-dimethyl-7-(3,4-methylenedioxobenzyl)-1-phenyl- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione
C31H35N3O4
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=9.2691(14)Å b=11.0898(11)Å c=12.802(2)Å
α=92.844(10)° β=95.185(12)° γ=91.070(11)°
3-<i>tert</i>-butyl-4',4'-dimethyl-1-phenyl-7-(3,4,5-trimethoxybenzyl)- 4,5,6,7-tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'- cyclohexane-2',6'-dione ethanol 0.67-solvate
C33H41N3O5,0.67(C2H6O)
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=13.5770(17)Å b=17.476(3)Å c=26.670(3)Å
α=90.00° β=90.00° γ=90.00°
4-(4-Chlorophenyl)-3,7,7-trimethyl-1-[2-(4-nitrobenzoyl)ethyl]-4,7,8,9- tetrahydro-1H-pyrazolo[3,4-b]quinolin-5(6H)-one-ethanol (1/1)
C28H27ClN4O4,C2H6O
Acta Crystallographica Section C (2001) 57, 11 1356-1358
a=23.6298(6)Å b=9.6215(3)Å c=14.2657(4)Å
α=90° β=120.2930(16)° γ=90°
1,3-dimethyl-7-(4-methylphenyl)pyrido[2,3-<i>d</i>]pyrimidine- 2,4(1<i>H</i>,3<i>H</i>)-dione
C16H15N3O2
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=6.9953(5)Å b=7.9221(7)Å c=12.5140(13)Å
α=93.466(4)° β=92.993(6)° γ=101.152(6)°
7-(biphenyl-4-yl)-1,3-dimethylpyrido[2,3-<i>d</i>]pyrimidine- 2,4(1<i>H</i>,3<i>H</i>)-dione
C21H17N3O2
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=7.2314(5)Å b=17.5834(18)Å c=12.4864(15)Å
α=90.00° β=97.782(8)° γ=90.00°
7-(4-fluorophenyl)-3-methylpyrido[2,3-<i>d</i>]pyrimidine- 2,4(1<i>H</i>,3<i>H</i>)-dione
C14H10FN3O2
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=6.7658(8)Å b=12.978(2)Å c=13.162(2)Å
α=90.00° β=90.00° γ=90.00°
C15H13N3O3
C15H13N3O3
Acta Crystallographica Section C (2009) 65, 4 o134-o139
a=6.6312(11)Å b=6.8121(15)Å c=27.653(7)Å
α=90.00° β=90.00° γ=90.00°
4-(2-Fluorophenyl)-6-(1<i>H</i>-indol-1-yl)-3-methyl-1-phenyl-1<i>H</i>- pyrazolo[3,4-<i>b</i>]pyridine-5-carbonitrile
C28H18FN5
Acta Crystallographica Section C (2009) 65, 8 o374-o376
a=24.155(3)Å b=10.5830(7)Å c=18.712(3)Å
α=90.00° β=105.743(10)° γ=90.00°
5-Amino-1-benzoyl-3-methylpyrazole
C11H11N3O
Acta Crystallographica Section C (2010) 66, 4 o159-o162
a=14.7443(6)Å b=5.7669(2)Å c=12.0082(3)Å
α=90.00° β=106.119(2)° γ=90.00°
2-amino-4-(piperidin-1-yl)-11<i>H</i>-pyrimido[4,5-<i>b</i>][1,5]benzodiazepin- 6-ium chloride monohydrate
C16H19N6,Cl,H2O
Acta Crystallographica Section C (2010) 66, 4 o154-o158
a=13.7831(14)Å b=7.5324(9)Å c=15.2987(12)Å
α=90.00° β=94.925(8)° γ=90.00°
2-amino-4-[methyl(2-methylphenyl)amino]-11<i>H</i>-pyrimido[4,5- <i>b</i>][1,5]benzodiazepin-6-ium chloride--benzene-1,2-diamine (1/1)
C19H19N6,Cl,C6H8N2
Acta Crystallographica Section C (2010) 66, 4 o154-o158
a=10.9559(13)Å b=11.2372(13)Å c=11.432(2)Å
α=102.894(12)° β=112.176(14)° γ=107.512(10)°
(<i>E</i>)-<i>N</i>^2^-{4-[(<i>E</i>)-2-(4-Chlorobenzoyl)ethenyl]-3-methyl- 1-phenyl-1<i>H</i>-pyrazol-5-yl}-<i>N</i>^1^,<i>N</i>^1^-dimethylformamidine
C22H21ClN4O
Acta Crystallographica Section C (2010) 66, 5 o245-o248
a=8.2228(3)Å b=8.3506(2)Å c=28.7043(10)Å
α=90.00° β=90.00° γ=90.00°
Benzo[<i>h</i>]pyrazolo[3,4-<i>b</i>]quinoline-5,6(10<i>H</i>)-dione
C27H17N3O2
Acta Crystallographica Section C (2010) 66, 6 o305-o309
a=15.436(5)Å b=13.622(7)Å c=9.359(5)Å
α=90.00° β=105.00(4)° γ=90.00°
8-methyl-7-(4-methylphenyl)-10-phenyl-5<i>H</i>- benzo[<i>h</i>]pyrazolo[3,4-<i>b</i>]quinoline-5,6(10<i>H</i>)-dione
C28H19N3O2
Acta Crystallographica Section C (2010) 66, 6 o305-o309
a=8.9952(15)Å b=9.6201(15)Å c=12.537(4)Å
α=98.72(2)° β=103.31(2)° γ=95.48(2)°
(Z)-5-(2-fluorobenzylidene)-2-thioxothaolidin-2-one
C10H6FNOS2
Acta Crystallographica Section C (2006) 62, 7 o382-o385
a=11.1848(4)Å b=7.7651(4)Å c=12.3611(5)Å
α=90.00° β=107.417(3)° γ=90.00°
(Z)-5-(4-fluorobenzylidene)-2-thioxothaolidin-2-one
C10H6FNOS2
Acta Crystallographica Section C (2006) 62, 7 o382-o385
a=4.9173(2)Å b=19.8906(10)Å c=10.4976(6)Å
α=90.00° β=92.929(3)° γ=90.00°
(Z)-5-(3,4,5-Trimethoxybenzylidene)-2-thioxothaolidin-2-one
C13H13NO4S2
Acta Crystallographica Section C (2006) 62, 7 o382-o385
a=10.3432(4)Å b=10.9105(4)Å c=13.4621(4)Å
α=100.399(2)° β=91.572(2)° γ=110.301(2)°
3-(5-Chloro-3-methyl-1-phenylpyrazol-4-yl)-1,5-diphenylpentane-1,5-dione
C27H23ClN2O2
Acta Crystallographica Section C (2006) 62, 8 o518-o520
a=15.2964(3)Å b=17.4366(2)Å c=16.8320(3)Å
α=90.00° β=90.00° γ=90.00°
7-Amino-2-tert-butyl-5-methylpyrazolo[1,5-a]pyrimidine
C11H16N4
Acta Crystallographica Section C (2007) 63, 1 o26-o28
a=10.8271(2)Å b=10.8271(2)Å c=19.9208(3)Å
α=90.00° β=90.00° γ=90.00°
7-amino-5-tert-butyl-2-methylpyrazolo[1,5-a]pyrimidine
C11H16N4
Acta Crystallographica Section C (2006) 62, 8 o521-o524
a=9.8216(5)Å b=11.3582(7)Å c=12.2783(8)Å
α=70.429(3)° β=69.895(4)° γ=66.454(4)°
3-(4-Methoxyphenyl)-7,7-dimethyl-1,6,7,8-tetrahydropyrazolo[3,4-b]quinolin-5-one
C19H19N3O2
Acta Crystallographica Section C (2006) 62, 8 o525-o527
a=7.1510(6)Å b=9.7680(7)Å c=12.3780(8)Å
α=72.094(5)° β=83.529(4)° γ=85.055(4)°
(E)-2-(2-thienyl)-3-(3,4,5-trimethoxyphenyl)acrylonitrile
C16H15NO3S1
Acta Crystallographica Section C (2006) 62, 9 o550-o553
a=22.5423(6)Å b=8.4647(3)Å c=7.4243(2)Å
α=90.00° β=91.510(2)° γ=90.00°
(E)-3-phenyl-2-(3-thienyl)acrylonitrile
C13H9NS
Acta Crystallographica Section C (2006) 62, 9 o550-o553
a=9.6280(11)Å b=5.7190(3)Å c=19.247(2)Å
α=90.00° β=103.129(7)° γ=90.00°
5-(2-Hydroxy-4,4-dimethyl-6-oxocyclohex-1-enyl)-3-methyl-2-(methylsulfanyl)- 6-phenyl-7H-pyrrolo[2,3-d]pyrimidin-4(3H)-one monohydrate
C22H23N3O3S,H2O
Acta Crystallographica Section C (2006) 62, 9 o554-o556
a=9.11880(12)Å b=11.3095(2)Å c=11.6526(2)Å
α=97.5471(10)° β=110.5868(10)° γ=104.4677(11)°
3-[5-(4-Bromophenyl)-1H-pyrazol-3-ylamino]-5,5-dimethylcyclohex- 2-en-1-one--(Z)-3-(4-bromophenyl)-3-chloroacrylonitrile (2:1)
2C17H18BrN3O,C9H5BrClN
Acta Crystallographica Section C (2006) 62, 10 o608-o611
a=13.4390(4)Å b=13.8680(4)Å c=46.1620(15)Å
α=90.00° β=93.050(2)° γ=90.00°
3,7-diamino-2,5-dimethylpyrazolo[1,5-a]pyrimidine monohydrate
C8H11N5,H2O
Acta Crystallographica Section C (2006) 62, 8 o521-o524
a=8.0970(2)Å b=9.8881(3)Å c=11.9661(3)Å
α=90.00° β=96.230(5)° γ=90.00°
(E)-3-(4-bromophenyl)-2-(2-thienyl)acrylonitrile
C13H8BrNS
Acta Crystallographica Section C (2006) 62, 9 o550-o553
a=3.8557(2)Å b=24.0484(7)Å c=12.5466(4)Å
α=90.00° β=96.877(2)° γ=90.00°
2,5-Dimethyl-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C16H15N3
Acta Crystallographica Section C (2007) 63, 8 o458-o461
a=7.9430(19)Å b=7.9660(11)Å c=9.943(3)Å
α=87.637(13)° β=82.632(18)° γ=89.941(17)°
2-tert-Butyl-5-methyl-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C19H21N3
Acta Crystallographica Section C (2007) 63, 8 o458-o461
a=11.2632(5)Å b=11.4574(7)Å c=12.1317(6)Å
α=93.449(5)° β=90.313(4)° γ=102.791(6)°
5-Amino-1-(4-methoxybenzoyl)-3-methylpyrazole
C12H13N3O2
Acta Crystallographica Section C (2008) 64, 2 o76-o79
a=6.1920(15)Å b=9.192(2)Å c=10.546(2)Å
α=73.69(2)° β=85.634(17)° γ=82.83(3)°
5-Amino-3-methyl-1-(2-nitrobenzoyl)pyrazole
C11H10N4O3
Acta Crystallographica Section C (2008) 64, 2 o76-o79
a=11.4212(15)Å b=7.1787(14)Å c=13.2595(10)Å
α=90.00° β=90.00° γ=90.00°
2-Hydroxyphenyl 2-methylpyrazolo[1,5-a]pyrimidin-6-yl ketone
C14H11N3O2
Acta Crystallographica Section C (2000) 56, 12 1455-1456
a=5.6004(2)Å b=11.8172(5)Å c=17.865(7)Å
α=90.00° β=98.71(16)° γ=90.00°
2,4-bis(2-hydroxybenzoyl)-2,3-dihydro-1H-pyrido[2,1-b][1,3]benzothiazole
C25H19NO4S
Acta Crystallographica Section C (2000) 56, 12 1460-1461
a=7.4978(15)Å b=11.265(2)Å c=12.322(3)Å
α=108.12(3)° β=99.38(3)° γ=94.75(3)°
2,2'-Methylenebis(3-hydroxy-5,5-dimethylcyclohex-2-en-1-one)
C17H24O4
Acta Crystallographica Section C (2003) 59, 12 o666-o668
a=18.8968(4)Å b=18.8989(4)Å c=8.7038(2)Å
α=90.00° β=90.00° γ=90.00°
5-methyl-2-phenyl-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C21H17N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=7.6223(2)Å b=16.7937(7)Å c=24.4900(9)Å
α=90.00° β=90.00° γ=90.00°
5-methyl-2-(4-methylphenyl)-6,7-dihydrobenzo[h]pyrazolo[1,5-a]quinazoline
C22H19N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=7.2767(13)Å b=29.924(6)Å c=8.0463(12)Å
α=90.00° β=112.590(6)° γ=90.00°
7-methyl-10-phenyl-5,6-dihydrobenzo[h]pyrazolo[5,1-b]quinazoline
C21H17N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=8.10920(10)Å b=11.7265(2)Å c=16.3486(3)Å
α=90.00° β=90.9010(12)° γ=90.00°
7-methyl-10-(4-methylphenyl)-5,6-dihydrobenzo[h]pyrazolo[5,1-b]quinazoline
C22H19N3
Acta Crystallographica Section C (2005) 61, 6 o398-o403
a=7.9037(7)Å b=13.1038(10)Å c=16.0576(13)Å
α=90.00° β=99.199(6)° γ=90.00°
3-(5-Chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-1-(4-methoxyphenyl)propenone
C20H17ClN2O2
Acta Crystallographica Section C (2005) 61, 6 o414-o416
a=12.7985(10)Å b=4.0684(3)Å c=16.6766(14)Å
α=90.00° β=95.918(4)° γ=90.00°
3-(5-Chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl)-1-(3,4,5- trimethoxyphenyl)propenone
C22H21ClN2O4
Acta Crystallographica Section C (2005) 61, 6 o414-o416
a=7.5118(2)Å b=8.8121(3)Å c=15.6709(4)Å
α=81.8250(10)° β=82.750(2)° γ=79.459(2)°
(<i>E</i>)-3-{2-Amino-4-ethoxy-6-[<i>N</i>-(4-methoxyphenyl)-N- methylamino]pyrimidin-5-yl}-1-phenylprop-2-en-1-one
C23H24N4O3
Acta Crystallographica Section C (2007) 63, 12 o758-o760
a=10.1975(14)Å b=10.959(2)Å c=11.046(2)Å
α=94.079(16)° β=109.845(11)° γ=113.339(10)°
2-<i>tert</i>-Butyl-5-methyl-7,8-dihydro-6<i>H</i>- cyclopenta[<i>e</i>]pyrazolo[1,5-<i>a</i>]pyrimidine
C14H19N3
Acta Crystallographica Section C (2008) 64, 9 o471-o473
a=6.8665(6)Å b=9.4084(14)Å c=11.147(2)Å
α=91.611(14)° β=107.728(14)° γ=111.097(12)°
9-Benzoyl-3,3,6,6-tetramethyl-1,2,3,4,5,6,7,8-octahydroxanthene-1,8-dione
C24H26O4
Acta Crystallographica Section C (2008) 64, 10 o554-o557
a=11.6394(15)Å b=11.5736(15)Å c=30.782(4)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-4-chloro-5-formyl-6-[methyl(2-methylphenyl)amino]pyrimidine
C13H13ClN4O
Acta Crystallographica Section C (2009) 65, 1 o11-o14
a=11.1502(8)Å b=8.7271(8)Å c=13.7129(13)Å
α=90.00° β=105.676(7)° γ=90.00°
2-amino-4-chloro-5-formyl-6-[(2-methoxyphenyl)methylamino]pyrimidine,
C13H13ClN4O2
Acta Crystallographica Section C (2009) 65, 1 o11-o14
a=11.301(4)Å b=8.642(3)Å c=14.568(5)Å
α=90.00° β=111.13(3)° γ=90.00°
2-Cyano-<i>N</i>-(4,6-dimethoxypyrimidin-2-yl)acetamide
C9H10N4O3
Acta Crystallographica Section C (2010) 66, 10 o521-o523
a=4.1760(6)Å b=11.296(2)Å c=12.070(3)Å
α=116.929(15)° β=90.478(13)° γ=95.767(15)°
6-Chloro-3-methyl-1,4-diphenylpyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C20H14ClN3O
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=16.784(3)Å b=9.6380(8)Å c=21.699(4)Å
α=90.00° β=108.820(12)° γ=90.00°
6-Chloro-3-methyl-4-(4-methylphenyl)-1-phenyl- pyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C21H16ClN3O
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=8.2898(8)Å b=9.9191(14)Å c=10.3666(10)Å
α=87.108(11)° β=86.808(8)° γ=85.088(12)°
6-Chloro-4-(4-chlorophenyl)-3-methyl-1- phenylpyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C20H13Cl2N3O
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=20.868(3)Å b=9.603(4)Å c=16.924(9)Å
α=90.00° β=90.00° γ=90.00°
4-(4-bromophenyl)-6-chloro-3-methyl-1- phenylpyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C20H13BrClN3O
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=9.3826(11)Å b=9.7781(12)Å c=10.1072(6)Å
α=108.077(10)° β=99.353(9)° γ=90.911(10)°
6-Chloro-4-(4-methoxyphenyl)-3-methyl-1- phenylpyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C21H16ClN3O2
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=8.6972(8)Å b=10.039(2)Å c=10.090(2)Å
α=85.23(2)° β=80.856(16)° γ=86.665(16)°
6-Chloro-3-methyl-4-(4-nitrophenyl)-1- phenylpyrazolo[3,4-<i>b</i>]pyridine-5-carbaldehyde
C20H13ClN4O3
Acta Crystallographica Section C (2012) 68, 1 o12-o18
a=11.7839(13)Å b=9.9890(4)Å c=15.71(2)Å
α=90.00° β=106.084(8)° γ=90.00°
(<i>E</i>)-3-<i>tert</i>-Butyl-4-(4-chlorobenzyl)-<i>N</i>-(4-chlorobenzylidene)-1-phenyl-1<i>H</i>-pyrazol-5-amine
C27H25Cl2N3
Acta Crystallographica Section C (2013) 69, 9 1039-1042
a=8.8820(5)Å b=10.1168(17)Å c=14.279(3)Å
α=69.627(13)° β=72.298(10)° γ=84.381(11)°
C35H31N3O
C35H31N3O
The Journal of organic chemistry (2015) 80, 19 9767-9773
a=10.1193(13)Å b=29.068(2)Å c=10.5161(10)Å
α=90.0° β=111.963(13)° γ=90.0°
C32H28ClN3
C32H28ClN3
The Journal of organic chemistry (2015) 80, 19 9767-9773
a=9.7402(4)Å b=11.0764(5)Å c=23.9164(11)Å
α=90.0° β=90.0° γ=90.0°
N^4^-Benzyl-N^4^-phenylyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine monohydrate
C18H16N6,H2O
Acta Crystallographica Section B (2008) 64, 5 610-622
a=10.1880(11)Å b=9.5136(10)Å c=33.695(4)Å
α=90.00° β=93.131(7)° γ=90.00°
(Z)-5-(4-methoxybenzylidenene)-2-thioxothiazolidin-4-one
C11H9NO2S2
Acta Crystallographica Section C (2005) 61, 8 o477-o482
a=5.1314(2)Å b=10.4543(5)Å c=20.5324(9)Å
α=90.00° β=91.702(2)° γ=90.00°
3-<i>tert</i>-Butyl-7-(4-methoxybenzyl)-4',4'-dimethyl-1-phenyl-4,5,6,7- tetrahydro-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-spiro-1'-cyclohexane- 2',6'-dione
C31H37N3O3
Acta Crystallographica Section C (2008) 64, 12 o665-o670
a=9.5971(8)Å b=11.2549(16)Å c=12.1452(14)Å
α=86.979(11)° β=85.487(10)° γ=87.216(7)°
5,5-dimethyl-3-(5-methyl-1H-pyrazol-3-ylamino)cyclohex-3-en-1-one
C12H17N3O
Acta Crystallographica Section C (2000) 56, 12 1457-1459
a=12.5130(3)Å b=9.4275(3)Å c=10.6441(3)Å
α=90.00° β=90.00° γ=90.00°
C35H35N3O3
C35H35N3O3
The Journal of organic chemistry (2015) 80, 19 9767-9773
a=10.63570(16)Å b=10.82044(18)Å c=26.4828(5)Å
α=90.0° β=91.8720(15)° γ=90.0°